Philippe Mourere

Company: Stilla Technologies

Job title: President & Chief Executive Officer

Seminars:

Getting De-Centralized Testing into Routine Clinical Oncology Using High-Performance Genetic Multiplexing Using Digital PCR 10:15 am

Bring uncompromised real-time oncology monitoring and management to patients High assay standardization and performance democratize this liquid biopsy tool for the absolute quantification of ctDNA, enabling longitudinal disease molecular assessment and treatment management Fixed or customized panels as companion diagnostics for seamless deployment directly into medical centersRead more

day: Day Two